[
  {
    "publication_date": "2026-03-09",
    "issuer": "SynAct Pharma AB",
    "lei": "549300RRYIEFEQ72N546",
    "reporting_person": "Quantass ApS",
    "person_in_leading_position": "Jeppe Øvli Øvlesen",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "SynAct Pharma AB",
    "isin": "SE0008241491",
    "transaction_date": "2026-03-05",
    "volume": 7900.0,
    "volume_raw": "7900,0",
    "volume_unit": "Antal",
    "price": 17.99311139,
    "price_raw": "17,99311139",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 142145.579981,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-03-09",
    "issuer": "SynAct Pharma AB",
    "lei": "549300O897ZC5H7CY412",
    "reporting_person": "Mads Liebach Bjerregaard",
    "person_in_leading_position": "Mads Liebach Bjerregaard",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "SynAct Pharma AB",
    "isin": "SE0008241491",
    "transaction_date": "2026-03-05",
    "volume": 1500.0,
    "volume_raw": "1500,0",
    "volume_unit": "Antal",
    "price": 17.92,
    "price_raw": "17,92",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 26880.000000000004,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-03-06",
    "issuer": "SynAct Pharma AB",
    "lei": "549300RRYIEFEQ72N546",
    "reporting_person": "Boesen Biotech ApS",
    "person_in_leading_position": "Thomas Boesen",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "SynAct Pharma AB",
    "isin": "SE0008241491",
    "transaction_date": "2026-03-03",
    "volume": 2700.0,
    "volume_raw": "2700,0",
    "volume_unit": "Antal",
    "price": 17.9,
    "price_raw": "17,9",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 48329.99999999999,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2026-03-06",
    "issuer": "SynAct Pharma AB",
    "lei": "549300RRYIEFEQ72N546",
    "reporting_person": "Boesen Biotech ApS",
    "person_in_leading_position": "Thomas Boesen",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "SynAct Pharma AB",
    "isin": "SE0008241491",
    "transaction_date": "2026-03-03",
    "volume": 2750.0,
    "volume_raw": "2750,0",
    "volume_unit": "Antal",
    "price": 17.92,
    "price_raw": "17,92",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 49280.00000000001,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-12-31",
    "issuer": "SynAct Pharma AB",
    "lei": "549300RRYIEFEQ72N546",
    "reporting_person": "TJ Biotech Holding Aps",
    "person_in_leading_position": "Thomas Jonassen",
    "position": "Annan ledande befattningshavare",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "SynAct Pharma AB",
    "isin": "SE0008241491",
    "transaction_date": "2025-12-19",
    "volume": 3529.0,
    "volume_raw": "3529,0",
    "volume_unit": "Antal",
    "price": 20.45,
    "price_raw": "20,45",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 72168.05,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-12-22",
    "issuer": "SynACt Pharma AB",
    "lei": "549300RRYIEFEQ72N546",
    "reporting_person": "Anders Kronborg",
    "person_in_leading_position": "Anders Kronborg",
    "position": "Styrelseordförande",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "SynAct Pharma AB",
    "isin": "SE0008241491",
    "transaction_date": "2025-12-19",
    "volume": 3470.0,
    "volume_raw": "3470,0",
    "volume_unit": "Antal",
    "price": 20.8361,
    "price_raw": "20,8361",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 72301.26699999999,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-12-22",
    "issuer": "SynAct Pharma AB",
    "lei": "549300RRYIEFEQ72N546",
    "reporting_person": "Quantass ApS",
    "person_in_leading_position": "Quantass ApS",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "SynAct Pharma AB",
    "isin": "SE0008241491",
    "transaction_date": "2025-12-17",
    "volume": 3529.0,
    "volume_raw": "3529,0",
    "volume_unit": "Antal",
    "price": 20.24067016,
    "price_raw": "20,24067016",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 71429.32499464,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-06-25",
    "issuer": "SynAct Pharma AB",
    "lei": "549300RRYIEFEQ72N546",
    "reporting_person": "Quantass ApS",
    "person_in_leading_position": "Jeppe Oevlesen",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "SynAct Pharma",
    "isin": "SE0008241491",
    "transaction_date": "2025-06-25",
    "volume": 2757.0,
    "volume_raw": "2757,0",
    "volume_unit": "Antal",
    "price": 17.551,
    "price_raw": "17,551",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 48388.106999999996,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-06-25",
    "issuer": "SynAct Pharma AB",
    "lei": "549300RRYIEFEQ72N546",
    "reporting_person": "Björn Westberg",
    "person_in_leading_position": "Björn Westberg",
    "position": "Ekonomichef/finanschef/finansdirektör",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "SynAct Pharma",
    "isin": "SE0008241491",
    "transaction_date": "2025-06-25",
    "volume": 2440.0,
    "volume_raw": "2440,0",
    "volume_unit": "Antal",
    "price": 17.52,
    "price_raw": "17,52",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 42748.799999999996,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-06-25",
    "issuer": "SynAct Pharma AB",
    "lei": "549300RRYIEFEQ72N546",
    "reporting_person": "TJ Biotech Holding Aps",
    "person_in_leading_position": "Thomas Jonassen",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "SynAct Pharma",
    "isin": "SE0008241491",
    "transaction_date": "2025-06-23",
    "volume": 18800.0,
    "volume_raw": "18800,0",
    "volume_unit": "Antal",
    "price": 16.313,
    "price_raw": "16,313",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 306684.39999999997,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-06-25",
    "issuer": "SynAct Pharma AB",
    "lei": "549300RRYIEFEQ72N546",
    "reporting_person": "Sten Sörensen",
    "person_in_leading_position": "Sten Sörensen",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "SynAct Pharma",
    "isin": "SE0008241491",
    "transaction_date": "2025-06-23",
    "volume": 3048.0,
    "volume_raw": "3048,0",
    "volume_unit": "Antal",
    "price": 16.411,
    "price_raw": "16,411",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 50020.728,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-06-25",
    "issuer": "SynAct Pharma AB",
    "lei": "549300RRYIEFEQ72N546",
    "reporting_person": "Anders Kronborg",
    "person_in_leading_position": "Anders Kronborg",
    "position": "Styrelseordförande",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "SynAct Pharma AB",
    "isin": "SE0008241491",
    "transaction_date": "2025-06-19",
    "volume": 6150.0,
    "volume_raw": "6150,0",
    "volume_unit": "Antal",
    "price": 16.188,
    "price_raw": "16,188",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 99556.2,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-06-25",
    "issuer": "SynAct Pharma AB",
    "lei": "549300RRYIEFEQ72N546",
    "reporting_person": "Boesen Biotech ApS",
    "person_in_leading_position": "Thomas Boesen",
    "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "SynAct Pharma",
    "isin": "SE0008241491",
    "transaction_date": "2025-06-19",
    "volume": 6250.0,
    "volume_raw": "6250,0",
    "volume_unit": "Antal",
    "price": 16.2208,
    "price_raw": "16,2208",
    "currency": "SEK",
    "trading_venue": "NASDAQ STOCKHOLM AB",
    "transaction_value": 101380.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-06-25",
    "issuer": "SynAct Pharma AB",
    "lei": "549300RRYIEFEQ72N546",
    "reporting_person": "Quantass ApS",
    "person_in_leading_position": "Jeppe Oevlesen",
    "position": "Verkställande direktör (VD)",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "SynAct Pharma",
    "isin": "SE0008241491",
    "transaction_date": "2025-06-19",
    "volume": 18500.0,
    "volume_raw": "18500,0",
    "volume_unit": "Antal",
    "price": 16.04426,
    "price_raw": "16,04426",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 296818.81,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-01-03",
    "issuer": "SynAct Pharma AB",
    "lei": "549300RRYIEFEQ72N546",
    "reporting_person": "Sten Sörensen",
    "person_in_leading_position": "Sten Sörensen",
    "position": "Styrelseledamot",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "SynAct Pharma AB",
    "isin": "SE0008241491",
    "transaction_date": "2025-01-03",
    "volume": 5780.0,
    "volume_raw": "5780,0",
    "volume_unit": "Antal",
    "price": 8.65,
    "price_raw": "8,65",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 49997.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-01-03",
    "issuer": "SynAct Pharma AB",
    "lei": "549300RRYIEFEQ72N546",
    "reporting_person": "Boesen Biotech ApS",
    "person_in_leading_position": "Thomas Boesen",
    "position": "Annan ledande befattningshavare",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "Aktie",
    "instrument_name": "SynAct Pharma AB",
    "isin": "SE0008241491",
    "transaction_date": "2024-12-30",
    "volume": 17341.0,
    "volume_raw": "17341,0",
    "volume_unit": "Antal",
    "price": 8.65,
    "price_raw": "8,65",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 149999.65,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-01-03",
    "issuer": "SynAct Pharma AB",
    "lei": "549300RRYIEFEQ72N546",
    "reporting_person": "BTB Consult Aktiebolag",
    "person_in_leading_position": "Björn Westberg",
    "position": "Ekonomichef/finanschef/finansdirektör",
    "closely_associated": "Ja",
    "correction": "Ja",
    "correction_description": "Fel transaktionsdatum",
    "first_report": "",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "SynAct Pharma",
    "isin": "SE0008241491",
    "transaction_date": "2024-12-30",
    "volume": 11560.0,
    "volume_raw": "11560,0",
    "volume_unit": "Antal",
    "price": 8.65,
    "price_raw": "8,65",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 99994.0,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-01-02",
    "issuer": "SynAct Pharma AB",
    "lei": "549300RRYIEFEQ72N546",
    "reporting_person": "TJ Biotech Holding Aps",
    "person_in_leading_position": "Thomas Jonassen",
    "position": "Annan ledande befattningshavare",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "Aktie",
    "instrument_name": "SynAct Pharma AB",
    "isin": "SE0008241491",
    "transaction_date": "2024-12-30",
    "volume": 28902.0,
    "volume_raw": "28902,0",
    "volume_unit": "Antal",
    "price": 8.65,
    "price_raw": "8,65",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 250002.30000000002,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2025-01-02",
    "issuer": "SynAct Pharma AB",
    "lei": "549300RRYIEFEQ72N546",
    "reporting_person": "Quantass ApS",
    "person_in_leading_position": "Jeppe Øvlesen",
    "position": "Verkställande direktör (VD), Styrelseledamot",
    "closely_associated": "Ja",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Teckning",
    "category": "other",
    "instrument_type": "Aktie",
    "instrument_name": "SynAct Pharma AB",
    "isin": "SE0008241491",
    "transaction_date": "2024-12-30",
    "volume": 28902.0,
    "volume_raw": "28902,0",
    "volume_unit": "Antal",
    "price": 8.65,
    "price_raw": "8,65",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 250002.30000000002,
    "status": "Aktuell",
    "is_current_report": true
  },
  {
    "publication_date": "2024-12-31",
    "issuer": "SynAct Pharma AB",
    "lei": "549300RRYIEFEQ72N546",
    "reporting_person": "Anders Kronborg",
    "person_in_leading_position": "Anders Kronborg",
    "position": "Styrelseordförande",
    "closely_associated": "",
    "correction": "",
    "correction_description": "",
    "first_report": "Ja",
    "share_program": "",
    "character": "Förvärv",
    "category": "acquisition",
    "instrument_type": "Aktie",
    "instrument_name": "SynAct Pharma AB",
    "isin": "SE0008241491",
    "transaction_date": "2024-12-30",
    "volume": 28902.0,
    "volume_raw": "28902,0",
    "volume_unit": "Antal",
    "price": 8.65,
    "price_raw": "8,65",
    "currency": "SEK",
    "trading_venue": "Utanför handelsplats",
    "transaction_value": 250002.30000000002,
    "status": "Aktuell",
    "is_current_report": true
  }
]